Sustainability Essentials

Overview

The report describes Novo Nordisk's 2024 reach of more than 45.2 million people with its medicines and 8.4 million vulnerable people living with diabetes reached. It introduces an absolute scope 3 emissions reduction target of 33% by 2033 and a net-zero ambition across scopes 1, 2 and 3 by 2045. The report also highlights workforce expansion to 77,349 employees and 42% female representation in senior leadership.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Condensed report
Fiscal year: 2024
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services